Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells
about
Small-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse ChemotherapeuticsRemoval of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved PharmacokineticsDerivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma.The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas.Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199).Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cells.Preclinical combination of TP-0903, an AXL inhibitor and B-PAC-1, a procaspase-activating compound with ibrutinib in chronic lymphocytic leukemiaMechanisms involved in reproductive toxicity caused by nickel nanoparticle in female rats.Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients.Mutations in the P10 region of procaspase-8 lead to chemotherapy resistance in acute myeloid leukemia by impairing procaspase-8 dimerization.
P2860
Q29027136-5C9843F3-B222-4218-A55E-0ADB4456702FQ35598226-D1B3A1D0-120D-4151-9364-DBD8F2F5A45CQ35859325-24FF6354-AB93-44B7-88B4-E06E1E8207F5Q36772172-67FC88B6-CFD7-4943-A226-5BB21437AB7FQ38764663-9C60C063-8AEE-4943-94BA-44232993C403Q39065374-F61610EF-5B57-4EA3-9B72-242E2B5F3806Q40643079-17074689-4590-4A97-9247-9C92AC6952F9Q41865162-31DFF809-269E-4CBC-8465-7071116576D9Q42696363-A2BBB036-B5A0-49A8-8402-3CA97C0E131AQ46549141-1E774CA7-45DF-49FD-948D-B5AFA6C5821CQ55302326-C5BDA246-D3F8-4230-9CE2-DB7E6FC8287F
P2860
Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expression of executioner proc ...... nic lymphocytic leukemia cells
@ast
Expression of executioner proc ...... nic lymphocytic leukemia cells
@en
Expression of executioner proc ...... nic lymphocytic leukemia cells
@nl
type
label
Expression of executioner proc ...... nic lymphocytic leukemia cells
@ast
Expression of executioner proc ...... nic lymphocytic leukemia cells
@en
Expression of executioner proc ...... nic lymphocytic leukemia cells
@nl
prefLabel
Expression of executioner proc ...... nic lymphocytic leukemia cells
@ast
Expression of executioner proc ...... nic lymphocytic leukemia cells
@en
Expression of executioner proc ...... nic lymphocytic leukemia cells
@nl
P2093
P2860
P1433
P1476
Expression of executioner proc ...... nic lymphocytic leukemia cells
@en
P2093
Kumudha Balakrishnan
Varsha Gandhi
Viralkumar Patel
P2860
P304
P356
10.1182/BLOOD-2014-01-546796
P407
P577
2014-12-23T00:00:00Z